BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33476766)

  • 1. Psychometric evaluation of a new drug-resistant tuberculosis stigma scale.
    Redwood L; Mitchell EMH; Nguyen TA; Viney K; Nguyen VN; Fox GJ
    J Clin Epidemiol; 2021 May; 133():101-110. PubMed ID: 33476766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation and validation of the Van Rie tuberculosis stigma scale in Vietnam.
    Redwood L; Mitchell EMH; Nguyen TA; Viney K; Duong L; Phạm HT; Nguyen BH; Nguyen VN; Fox GJ
    Int J Infect Dis; 2022 Jan; 114():97-104. PubMed ID: 34715359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam.
    Redwood L; Mitchell EMH; Viney K; Snow K; Nguyen TA; Dung LAT; Nguyen VN; Fox GJ
    Int J Tuberc Lung Dis; 2021 Jun; 25(6):461-467. PubMed ID: 34049608
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?
    Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES
    BMC Infect Dis; 2017 Jan; 17(1):36. PubMed ID: 28061832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Xpert MTB/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study.
    Wang P; Gu J; Yang J; Yang C; Wu X; Yu F; Fan L
    Ann Palliat Med; 2020 Mar; 9(2):239-246. PubMed ID: 32233619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stigma towards people with tuberculosis: a cross-cultural adaptation and validation of a scale in Indonesia.
    Fuady A; Arifin B; Yunita F; Rauf S; Fitriangga A; Sugiharto A; Yani FF; Nasution HS; Putra IGAE; Mansyur M; Wingfield T
    BMC Psychol; 2023 Apr; 11(1):112. PubMed ID: 37055814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of anxiety and depression in patients with multi-drug/rifampicin-resistant tuberculosis.
    Dan-Ni Z; Guang-Min Z; Yu-Hua D; Ying L; Ting W; Yuan-Yuan C; Yu-Hong X; Xin-Cai X
    Front Public Health; 2024; 12():1372389. PubMed ID: 38601494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of scaling up Xpert
    Awan WM; Zaidi SMA; Habib SS; Khowaja S; Malik A; Khan U; Ferrand RA; Creswell J; Khan A
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):899-904. PubMed ID: 29991399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different profiles of body mass index variation among patients with multidrug-resistant tuberculosis: a retrospective cohort study.
    Diallo A; Diallo BD; Camara LM; Kounoudji LAN; Bah B; N'Zabintawali F; Carlos-Bolumbu M; Diallo MH; Sow OY
    BMC Infect Dis; 2020 Apr; 20(1):315. PubMed ID: 32345228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis patients are physically challenged and socially isolated: A mixed methods case-control study of Health Related Quality of Life in Eastern Ethiopia.
    Roba AA; Dasa TT; Weldegebreal F; Asfaw A; Mitiku H; Teklemariam Z; Naganuri M; Geddugol BJ; Mesfin F; Befikadu H; Tesfaye E
    PLoS One; 2018; 13(10):e0204697. PubMed ID: 30321189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Multi-Drug Resistant Tuberculosis Diagnosis and Treatment Cascade in Bangladesh.
    Hossain ST; Isaakidis P; Sagili KD; Islam S; Islam MA; Shewade HD; Kamal SM; Husain A
    PLoS One; 2015; 10(6):e0129155. PubMed ID: 26110273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013-2015: A retrospective cohort study.
    Chaves-Torres NM; Fadul S; Patiño J; Netto E
    PLoS One; 2021; 16(4):e0249565. PubMed ID: 33852619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review.
    Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K
    PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and psychometric properties of the bipolar disorders knowledge scale.
    Stump TA; Eng ML
    J Affect Disord; 2018 Oct; 238():645-650. PubMed ID: 29957482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental health disorders, social stressors, and health-related quality of life in patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
    Alene KA; Clements ACA; McBryde ES; Jaramillo E; Lönnroth K; Shaweno D; Gulliver A; Viney K
    J Infect; 2018 Nov; 77(5):357-367. PubMed ID: 30036607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Introducing Xpert MTB/RIF to Test and Treat Individuals at Risk of Multidrug-Resistant Tuberculosis in Kazakhstan: A Prospective Cohort Study.
    van Kampen SC; Tursynbayeva A; Koptleuova A; Murzakhmetova Z; Bigalieva L; Aubakirova M; Pak S; van den Hof S
    PLoS One; 2015; 10(7):e0132514. PubMed ID: 26181578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.